Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Kelly

Vascular Surgery Atlantis, FL Medical Doctor

NPI 1598053803 CMS profile 522555

180 Jfk Dr Ste 320, Atlantis, FL 33462

Open in the dashboard

General payments

$14,357

211 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Kelly of Atlantis, FL is reported in the CMS Open Payments database as having received $14,357 across 211 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,176 40
2024 General $1,886 42
2023 General $4,788 43
2022 General $2,704 29
2021 General $1,700 15
2020 General $124 8
2019 General $979 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Kelly
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Brian Kelly were reported at $2,176. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Brian Kelly Vascular Surgery median Middle half National median
2019 $979 $796 $226–$2,363 $163
2020 $124 $348 $118–$1,110 $114
2021 $1,700 $471 $158–$1,421 $132
2022 $2,704 $725 $222–$2,183 $149
2023 $4,788 $836 $257–$2,440 $160
2024 $1,886 $909 $252–$2,619 $164
2025 $2,176 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $3,090 17 payments
  2. Inari Medical, Inc. $3,053 28 payments
  3. W. L. Gore & Associates, Inc. $843 6 payments
  4. Boston Scientific Corporation $635 14 payments
  5. Silk Road Medical, Inc. $626 5 payments
  6. Cook Medical LLC $610 8 payments
  7. Philips Electronics North America Corporation $561 10 payments
  8. Medtronic, Inc. $505 11 payments
  9. Janssen Pharmaceuticals, Inc $473 15 payments
  10. CVRx, Inc. $396 11 payments
  11. Other $3,566 86 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $12,978 206 payments
  2. Travel and Lodging $1,342 3 payments
  3. Education $37 2 payments
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $3,108 29 payments
  2. CT THROMBECTOMY SYSTEM KIT $2,997 27 payments
  3. Indigo System $2,899 14 payments
  4. ENROUTE Transcarotid Stent $600 4 payments
  5. ENROUTE Transcarotid Neuroprotection System $600 4 payments
  6. Zenith $590 7 payments
  7. XARELTO $473 15 payments
  8. Barostim Neo System $396 11 payments
  9. GORE TAG Conformable Thoracic Endoprosthesis $289 2 payments
  10. Restrata Wound Matrix $262 3 payments
  11. Other $9,011 201 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

36

Median for Vascular Surgery: 122

Drug cost

$181

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 18 $108
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 18 $74

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$131,595

Medicare's payments for the services billed

Medicare patients

316

Average age 73

Services billed

987

132 women, 184 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 59%
Ischemic heart disease 59%
Chronic kidney disease 58%
Heart failure 47%
Arthritis 46%
Atrial fibrillation 34%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

211 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record